Company: XERI
Filing Date: 2025-10-02
Form Type: 10-K
Source: 0001477932-25-007303
Chunk: 747

Company: XERIANT, INC.
Filing Date: 2025-10-02
Form: 10-K
Item: Item 8
Chunk 747
---
   1,853,323   2,132,529 Lease liability, current  4,279   36,197 Total current liabilities  8,765,577   9,325,459          Lease liability, long-term  3,105   - Total liabilities  8,768,682   9,325,459          Commitments and contingencies (Note 8)                 Stockholders’ deficit        Preferred stock, $0.00001 par value; 100,000,000 shares authorize        Series A Preferred stock, 3,500,000 designated; 664,996 and 705,895 shares issued and outstanding at June 30, 2025 and 2024, respectively  7   7 Series B Preferred stock, 1,000,000 designated; 1,000,000 issued and outstanding  10   10 Common stock, $0.00001 par value; 5,000,000,000 shares authorized; 695,746,625 and 524,853,304 shares issued and outstanding at June 30, 2025 and 2024, respectively  6,958   5,248 Common stock to be issued  97,900   51,950 Additional paid-in capital  22,410,416   20,899,187 Accumulated deficit  (28,338,606)  (26,708,915)Total stockholders’ deficit  (5,823,315)  (5,752,513)Non-controlling interest  (2,877,148)  (2,859,941)Total stockholders’ deficit  (8,700,463)  (8,612,454)Total liabilities and stockholders’ deficit $68,219  $713,005 

The accompanying notes are an integral part of these consolidated financial statements. 

 F-3Table of Contents

XERIANT, INC. 

CONSOLIDATED STATEMENTS OF OPERATIONS 

  For the years ended   June 30,   2025  2024 Operating expenses:      Consulting and advisory fees $327,991  $731,128 Related party consulting fees  438,000   388,000 General